Leaderboards/Spondyloarthritis Studies and Treatments

Spondyloarthritis Studies and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Olivier Fakih
Université de franche-comté
2
S. Kieskamp
University Medical Center Groningen
3
Selinde V J Snoeck Henkemans
Erasmus MC
4
Iain B. McInnes
University of Glasgow
5
Junlai Wu
Tongji Hospital
6
Mary Lucy Marques
Leiden University Medical Center
7
Cécile Philippoteaux
Université de Lille
8
María Laura Acosta Felquer
Hospital Italiano de Buenos Aires
9
Zhaoxin Ma
Army Medical University
10
Kalliopi Klavdianou
Rheumazentrum Ruhrgebiet

Papers

1
Window of opportunity in psoriatic arthritis: the earlier the better?
RMD Open|2024
37 cit.
2
Publication in Annals of the Rheumatic Diseases (2024) [30 citations, W4390939541]
Annals of the Rheumatic Diseases|2024
30 cit.
3
Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis
Lara D. Veeken|2024
14 cit.
4
Publication in Nature Medicine (2025) [12 citations, W4414849140]
Nature Medicine|2025
12 cit.
5
Interrelationships of disease activity, central sensitization, psychosocial and lifestyle factors in axial spondyloarthritis
Lara D. Veeken|2025
10 cit.
6
Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity
RMD Open|2024
7 cit.
7
Publication in RMD Open (2024) [4 citations, W4390719388]
RMD Open|2024
4 cit.
8
Marrow Adiposity Content and Composition Are Not Associated With Incident Fragility Fractures in Postmenopausal Women: The ADIMOS Fracture Study
Journal of the Endocrine Society|2025
4 cit.
9
Comment on: Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis: Reply
Lara D. Veeken|2024
2 cit.
10
Publication in Clinical Rheumatology (2025) [2 citations, W4410398359]
Clinical Rheumatology|2025
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
William Tillett
Royal United Hospital Bath NHS Trust
2
Agnieszka Zielińska
Centrum Medyczne iMed24
3
Pengfei Chen
Children's Hospital of Chongqing Medical University
4
José U. Scher
New York University
5
Peimin Wang
Peking University
6
M. Viguier
Unknown
7
Carlos Pantojas
Clinical Research Puerto Rico
8
Jacqueline B. Palmer
Novartis (United States)
9
Nele Herregods
Alberta Hospital Edmonton
10
Todd Fox
Novartis (Switzerland)

Papers

1
A plant-derived natural photosynthetic system for improving cell anabolism
Nature|2022
235 cit.
2
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
Materials Today Bio|2022
60 cit.
3
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
BMJ Open|2022
53 cit.
4
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin
Annals of the Rheumatic Diseases|2022
47 cit.
5
A natural extracellular matrix hydrogel through selective nutrient restriction for hyperinflammatory starvation therapy
Matter|2022
27 cit.
6
Gallic acid ameliorates synovial inflammation and fibrosis by regulating the intestinal flora and its metabolites
Toxicology and Applied Pharmacology|2024
23 cit.
7
MRI-based synthetic CT for assessment of the bony elements of the sacroiliac joints in children
Insights into Imaging|2024
22 cit.
8
The Lineage Differentiation and Dynamic Heterogeneity of Thymic Epithelial Cells During Thymus Organogenesis
Frontiers in Immunology|2022
20 cit.
9
NGF Signaling Exacerbates KOA Peripheral Hyperalgesia via the Increased TRPV1-Labeled Synovial Sensory Innervation in KOA Rats
Pain Research and Management|2024
18 cit.
10
siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma
International Immunopharmacology|2022
17 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Joachim Sieper
Charité - Universitätsmedizin Berlin
2
Désirée van der Heijde
Leiden University Medical Center
3
Jürgen Braun
Center for HIV and Hepatogastroenterology
4
Dafna D. Gladman
Toronto Western Hospital
5
Philip Helliwell
University of Leeds
6
Matthew A. Brown
Translational Research Institute
7
Walter P. Maksymowych
University of Alberta
8
Robert D. Inman
University of Toronto
9
Andrei Călin
Universitatea Națională de Știință și Tehnologie Politehnica București
10
Oliver FitzGerald
University College Dublin

Papers

1
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Annals of the Rheumatic Diseases|2009
3.6k cit.
2
SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX
Elsevier eBooks|2007
3k cit.
3
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Annals of the Rheumatic Diseases|2020
2.8k cit.
4
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Annals of the Rheumatic Diseases|2022
1.8k cit.
5
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Annals of the Rheumatic Diseases|2013
1.8k cit.
6
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
Annals of the Rheumatic Diseases|2010
1.7k cit.
7
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
Annals of the Rheumatic Diseases|2009
1.6k cit.
8
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
The Lancet|2002
1.3k cit.
9
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Annals of the Rheumatic Diseases|1990
1.1k cit.
10
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
Annals of the Rheumatic Diseases|2008
1.1k cit.

Reagents for Spondyloarthritis Studies and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Nod1 Antibody

#3545$317
View Evidence →
Cell Signaling TechnologyEvidence 65

MLXIP/MondoA (F8A8L) Rabbit Monoclonal Antibody

#72133$161,376
View Evidence →
Cell Signaling TechnologyEvidence 64

FGF Receptor 4 (D3B12) Rabbit Monoclonal Antibody

#8562$159,381
View Evidence →

🌟 All-Time

Most validated

Fitzgerald Industries International

Tricyclic Antidepressant-BSA

Cited in 6 papers
#BSA
View Evidence →
Cell Signaling TechnologyEvidence 66

Total SAPK/JNK Matched Antibody Pair

#74090$1,726
View Evidence →
Cell Signaling TechnologyEvidence 68

ASC/TMS1 (D2W8U) Rabbit Monoclonal Antibody

#67824$151,351
View Evidence →